Nov 2020
Mechanical chest compressions and simultaneous defibrillation VS conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest - the LINC randomized trial
Esibov A et al. Resuscitation 2015;91:116-121.
- The LINC trial was designed to compare manual CPR and mechanical CPR. Adult patients with unexpected out-of-hospital cardiac arrest were started on manual CPR and immediately randomised into either group using sealed opaque envelopes at the patient’s side.
- Patients with traumatic cardiac arrest, pregnancy, extreme body habitus, defibrillation before the device arrived on scene or crew-witnessed cardiac arrest were excluded from the study.
- Primary out was defined as 4-hour survival after successful ROSC. Secondary outcome included ROSC, arrival to emergency department with a pulse, survival with good neurological recovery. In terms of both primary and secondary outcomes, there was no significant difference between the two groups.
- A point to note from the LINC trial is that the manual CPR and mechanical CPR groups utilise two different protocols. The protocol for manual CPR group is similar to the 2005 European Resuscitation Council guidelines. The protocol for mechanical CPR included 3 minutes of mechanical compression, first defibrillation after 90s during ongoing mechanical compressions regardless of initial rhythm, first rhythm check after 3 minutes of mechanical compression.
- Link to article
Nov 2020
ACLS 2020 update: 2020 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care
Basic and advanced life support writing groups 2020
- The main points of this update were summarized in the powerpoint below. Changes include: Early initiation of CPR by lay rescuers; Early administration of epinephrine; Real time audiovisual feedback during CPR; Physiological monitoring of CPR quality; Double sequential defibrillation NOT supported; IV access preferred over IO etc. See powerpoint for details.
- Link to powerpoint file
- Link to article
Jun 2020
The Saline or Lactated Ringer's (SOLAR) Trial
Maheshwari K et al. Anesthesiology 2020;132:614-624.
- Background: SOLAR trial is by far the largest perioperative study to address the clinical question of normal saline vs. balanced crystalloid. Normal saline is known to cause hyperchloremic metabolic acidosis. In a few studies, it was shown to increase adverse renal events, compared with balanced crystalloid. However, most of these studies are conducted in ICU / AED. Surgical patients have different characteristics:
- Less ill
- Shorter duration of care
- Small amount or dose of fluid given
- Under the effect of anesthetics & surgery
- Study design & internal validity; PICO
- Patients
- Single center in American
- Elective ORT / CR surgery; within a 3 years study interval
- Exclusion: EOT, OT < 2h, ASA >= 5, on dialysis / missing preop Cr
- N = 8616 after inclusion-exclusion
- Exposure to LR / saline, assign according to alternating time interval of 2 weeks
- Intervention
- Comparison
- Normal saline, median 1.9 L as well
- Outcomes
- Primary, secondary: no clinically meaningful difference; also statistically insignificant
- Analysis by GEE to give relative risk, 95% CI & P value (Primary RR 1.16, Secondary RR 1.18)
- P value is not 0.05 – Interim analysis (issue of alpha spending), Multiple measurement (Bonferroni correction)
- Significant results:
Less RBC transfusion in LR : RR=0.84, p<0.001 --> No compelling explanation
Lower Na, Cl, higher HCO3 in LR (not surprising considering the composition of LR)
- Results
- Blinded observer interviewed the patients for awareness at the 1st and 4th day after surgery with a structured questionnaire. The patients who were evaluated as 'awareness' by either of two interviews were classified into awareness. An independent evaluating committee assessed the interview results and identified the confirmed or possible awareness cases. The intraoperative BIS values and trends were downloaded at regular intervals.
- Strength
- Large, prospective, relevant to clinical practice (ORT/CR >= 2h, 2L fluid), few cross-over ~4%, baseline balance between groups is excellent, statistical analysis to account for (confounder: IRWT, E value; within subject component: GEE; multiple measurement: Bonferroni correction)
- Weakness
- observational, no true randomization, other intraop and post-op management not controlled (technique – anaesthetic, surgical; drugs – vasopressor, nephrotoxic drugs; physiological aims – MAP, urine output target), exact type of operation and complications unknown, possible under-reporting (data collection by electrical medical system), under-power due to lower-than-expected incidence
- External validity
- Context of study is relevant to our practice: Elective ORT / CR surgery; Lasting ~4h, with ~2L fluid given
- But patient characteristics are different: ASA, race, usual medication, BMI
- Surgical & anaesthetic practice can be different
- Not applicable for procedure with specific concerns of fluid & blood management, e.g. Neurosurgery, Flap reconstruction, Ultra-major invasive surgery (esophagectomy, Whipple’s), Lung resection, etc.
- Link to article
Jun 2020
NAP4: Major Complications of Airway Management in the United Kingdom
NAP4 study investigators 2011
- Census of the airway management techniques over a 2 week period (Part 1) . A total of 114,904 GA cases recorded
- Major airway events that occurred over a 12 month period (Part 2)
Minimum annual incidence rate = 1 per 22,000 GA
Inclusion criteria: death, brain damage at one month, need for emergency surgical airway, unanticipated ICU admission or prolongation of ICU stay
Occurs most commonly during induction but also notably with almost 1/3 during emergence & recovery phase
- Difficult or delayed intubation, failed intubation and ‘can’t intubate can’t ventilate’ (CICV) were most prominent events
- Aspiration , was the commonest primary cause of fatality
- Vulnerable population involved patients with head and neck cancer and and obesity
- Approximately 65% of cricothyroidotomy attempts by anaesthestists failed to secure the airway
- Contributing factors
- Poor airway assessment
- Poor planning (–> with potentially difficult airway management, a strategy is required)
- Failure to plan for failure (e.g. CICO guideliens)
- Many cases where AFOBI is indicated but not used
- Inappropriate use of supraglottic airway device
- Link to article
Jan 2020
Bispectral index monitoring prevent awareness during total intravenous anesthesia: a prospective, randomized, double-blinded, multi-center controlled trial
Zhang C et al. Chinese Med J 2011;124:3664-3669.
- This study compared the effect of BIS monitoring on the incidence of awareness between BIS-guided and routine TIVA protocol groups. The authors quoted an incidence of awareness of 1% in China.
- Patients – >= 18 years of age, without any apparent mental defect undergoing TIVA
- Intervention - BIS was monitored and recommended to maintain between 40-60
- Control – BIS was monitored but the screen was covered
- Outcome - incidence of awareness due to light anesthesia
- Was the assignment of patients to treatments randomized? Yes. Randomization was carried out in each of the 13 domestic academic general hospitals through computer generated random numbers. According to the parity of the number, they were divided into Group A (BIS-guided anesthesia group) or Group B (control group).
- Were the groups similar at baseline?
- No. The ASA status, surgical history and type of surgery were statistically different between the two groups.
- Were the groups treated equally aside from the allocated treatment?
- No. Other types of anesthetics (analgesics and muscle relaxants) and the doses administered were left to the discretion of the anesthetist taking charge of the TIVA.
- Were all patients entered trial accounted for?
- No. Outcome data was collected from 5309 patients.
- 54 cases were withdrawn because the information of group allocation was unavailable (without awareness cases). 21 patients were excluded due to age younger than 18 years old (11 cases in Group A, and 10 cases in Group B).
- 6 patients were excluded because of failure to be interviewed at either of the two times (2 cases in Group A, 2 cases in Group B; 1 patient died postoperatively, 1 case cancelled operation after anesthesia induction)
- A total of 5228 cases were enrolled in the final statistical analysis with 2919 cases in Group A and 2309 cases in Group B
- Blinded?
- Interviewers and patients were blinded to the group allocation. Anesthetists performing TIVA were not blinded. Observers interviewing patients on post-op 1st and 4th day were blinded.
- Data collection/processing
- Blinded observer interviewed the patients for awareness at the 1st and 4th day after surgery with a structured questionnaire. The patients who were evaluated as 'awareness' by either of two interviews were classified into awareness. An independent evaluating committee assessed the interview results and identified the confirmed or possible awareness cases. The intraoperative BIS values and trends were downloaded at regular intervals.
- Results
- Statistically significant: confirmed awareness
- 4 (0.14%) in BIS-guided group vs. 15 (0.65%) in control group
- Significant difference in the incidence of awareness between the two groups (P=0.002, OR=0.21, 95% CI: 0.07-0.63)
- BIS-guided TIVA reduced the incidence of awareness by 78%
- NOT statistically significant: possible awareness and dreaming
- possible awareness (0.14% vs. 0.26%, P=0.485) and dreaming (3.1% vs. 3.1%, P=0.986) was comparable between the BIS-guided group and the control group
- Conclusion:
- BIS-guided TIVA (BIS was recommended to maintain between 40-60) decreased the risk of awareness compared with routine TIVA.
- Strenths
- Large, multicentered trial in Mainland China
- Strict randomization
- Weaknesses
- Types of anesthetics administered were left to discretion of anesthetists. Use of analgesics can lead to reduced awareness or a higher BIS number with use of ketamine while use of muscle relaxants can lead to change in EMG activity and hence change of BIS value
- Patient characteristics (ASA status, surgical history and type of surgery) significantly different between two groups –> could possibly be minimized by stratified randomization
- Most of the patients recruited are ASA 1 or 2 patients with no patients recruited for obstetrics cases.
- Follow-up limited on 1st and 4th day post-op
- Wide 95% Confidence interval 0.07-0.63 leading to limited precision
- This study quoted incidence of awareness under TIVA in China as 1% according to a previous survey but with no reference quoted. 1% is far higher than the generally accepted incidence of ~0.1-0.2%.
- External validity
- This study was conducted in Mainland China with the same ethnicity as us.
- BIS is also easily accessible in our operating theatres with little harm applying on patients. However, this study has quite a lot of weaknesses mentioned above that limited its applicability in our daily practices. Overall, BIS monitoring is beneficial to be applied in selected cases to reduce possible risk of awareness.
- Apart from propofol, also gives midazolam IV as induction agent which is not a common practice in HK.
- Link to article
Jan 2020
Accidental awareness during general anaesthesia in the United Kingdom and Ireland - the NAP5 study
Nov 2019
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial
CRASH-3 Trial Collaborators. Lancet 2019;394:1713-1723.
- The effects of tranexamic acid in patients with traumatic brain injury (TBI) were assessed.
- Patients – Adults with TBI who were within 3h of injury, had a GCS score of <=12 or any intracranial bleeding on CT scan, and no major extracranial bleeding
- Intervention - a loading dose of 1g of tranexamic acid infused over 10 min, started immediately after randomisation, followed by an intravenous infusion of 1g over 8 h
- Control – placebo 0.9% NaCl
- Outcome (Primary) Head injury-related death in hospital within 28 days
- Secondary outcomes: early head injury-related death (within 24 h after injury), all-cause and cause-specific mortality, disability, vascular occlusive events (myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism), seizures, complications, neuro-surgery, days in intensive care unit, and adverse events within 28 days
- Null hypothesis: administration of tranexamic acid (TXA) under 3 hours from injury, compared with placebo, does not reduce head injury associated in-hospital mortality within 28 days
- Were the groups similar at baseline?
- Baseline characteristics (sex, age, time since injury, SBP, GCS, pupillary reaction) well matched
- Were the groups treated equally aside from the allocated treatment?
- No information published regarding ongoing management
- Were all patients entered trial accounted for?
- 12737 patients randomized
- 6406 to TXA of which 4649 were randomised <3hrs; 4613 / 4649 analysed (13 withdrew consent, 7 had data unavailable and 29 lost to follow-up)
- 6331 to placebo of which 4553 were randomised <3h; 4514 / 4553 analysed (19 withdrew consent, 14 data unavailable and 25 lost to follow up)
- Blinded?
- Yes – Participants are blinded; study staff (site investigators and trial coordinating centre staff) are blinded
- Results
- 28 day in-hospital head injury associated mortality in patients assigned within 3 hours of injury - no significant difference
TXA group 855/4613 (18.5%) vs. 892/4514 (19.8%) in placebo
RR 0.94 (95% CI 0.86 – 1.02)
ARR 1.23% (95% CI -0.39 – 2.84%)
- Patients with Mild to Moderate TBI (GCS 9-15) – significantly reduced in TXA group in 28d mortality
TXA group 5.8% vs placebo group 7.5%, RR 0.78 (95% CI 0.64-0.95)
- Pre-specified Subgroup Analysis of Primary Outcome: Excluding those with GCS 3 or bilateral unreactive pupils – no significant difference
- Other secondary outcomes:
Timing of TXA: Early treatment was more effective than later treatment in mild to moderate injury (p=0.005), but timing had no effect in severe injury
Disability measures & complications were similar between groups. No increased risk of vaso-occlusive events (1.6% in both groups) or seizures (TXA group 3.2%% vs placebo 3.0%)
- Conclusion:
- Tranexamic acid is safe in patients with TBI and that treatment within 3 h of injury reduces head injury-related death. There was no statistical difference in the primary outcome of head injury related death.
- Strenths
- Large, multicentered trial across many countries
- Strict randomization and blinding
- Minimal loss of follow up
- Small number of protocal variations
- Considered patient focused outcome eg. Patient derived disability measures
- Weaknesses
- Did not mention the management common in both groups and pre-hospital interventions
- Potential recall and observer bias in determining TBI associated death
- Follow up only limited to 28 days
- The primary outcome has a 95% CI that crosses zero, the conclusion is not statistically correct
- External validity
- Did not mention the management common in both groups and pre-hospital interventions
- Potential recall and observer bias in determining TBI associated death
- Follow up only limited to 28 daysp
- The primary outcome has a 95% CI that crosses zero, the conclusion is not statistically correct
- Link to article
Nov 2019
Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial
CRASH trial collaborators. Lancet 2004;364:1321-28.
- A randomized controlled trial on the effect of corticosteroids on death and disability after head injury
- 10,008 adults over 16years old were recruited, across 49 countries
- Recruited patients with clinically significant head injury with a GCS of =< 14, presenting within 8hr of injury; exclusion criteria: any contraindication for steroids
- patients were given methylprednisolone loading dose of 2g over 1 hour, then maintenance 0.4g per hour for 48hr vs placebo
- Primary outcome: death within 14d; secondary outcome: mortality/ severe disability at 6months
- results: risk of death was higher in corticosteroid group than in placebo group (25.7% vs 22.3%, RR 1.15, CI 1.07-1.24, p=0.0001)
- conclusion: steroids should not be routinely used to treat HI, whatever the severity
- Link to article
Nov 2019
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
CRASH-2 trial collaborators. Lancet 2010;376:23-32.
- a randomized controlled trial to assess the effects of early administration of tranexamic acid in bleeding trauma patients
- 202,011 adults in 40 countries were recruites
- included trauma patients with significant hemorrhage or at risk of bleeding
- patients were either given transamine 1g loading over 10min, then 1g over 8hr, vs placebo
- primary outcome: all-cause death within 4weeks
- Results:
- There is overall reduction in mortality due to bleeding in transamine group (RR 0.85, 95% CI 0.76-0.96, p=0.0077); there is no significant effect on the risk of death for all other (non-bleeding) causes combined (RR 0.94, 95% CI 0.86-1.02, p = 0.13)
- when administered early (<1hr from injury), there is greater reduction in death due to bleeding, RR 0.68
- when administered at 1-3hours, RR 0.79
- when administered later (>3hr from injury), there is increase in bleeding death, RR 1.44
- there is no increase in vascular occlusive events (MI/ CVA/ DVT/ PE) in the intervention group
- there is no reduction in transfusion requirements
- Conclusion: transamine can improve survival when given early in trauma with known or suspected significant hemorrhage; however, if given late (>3hours from time of injury), it is less effective and may be harmful.
- Link to article
Oct 2019
Effects of transversus abdominis plane blocks after hysterectomy: a meta-analysis of randomized controlled trials
Leung AA et al. Journal of Pain Research 2018;11:2477-2489.
- This meta-analysis was conducted to investigate the effectiveness of TAP block after hysterectomy:
- Patients – Initial search from PubMed (n=364), MEDLINE (n=53), EMBASE (n=95), Cochrane Library (n=73), Web of Science (n=49), and ClinicalTrials.gov (n=7) databases; 13 prospective randomized controlled studies published from 2008 to 2016; 841 participants were included. Types of hysterectomy: 8 studies underwent total/partial AH and 5 studies underwent LH/RH. All used standard GA
- Intervention - Pre-/post-op TAP block
- Control – No or sham block
- Outcome (Primary) Mean 24-hr morphine consumption
- Secondary outcomes: Time to first request for analgesic, Pain score at rest, Pain score on movement at different times postoperatively, including 2, 4, 6–8, 12, 24, and 48 hours. Quality of recovery score (QoR-40) –> 40-item questionnaire intended to measure quality of recovery grouped according to various aspects (dimensions) of recovery: i) emotional state (n 9) ii) physical comfort (n 12) iii) psychological support (n 7) iv) physical independence (n 5) v) pain (n 7). Adverse events: Rate of N&V
- Search for relevant studies comprehensive?
- Initial search from PubMed (n=364), MEDLINE (n=53), EMBASE (n=95), Cochrane Library (n=73), Web of Science (n=49), and ClinicalTrials.gov (n= 7) databases
- Search results were limited to English
- Two authors (HZ and JP) performed the searches and independently reviewed and extracted data from each study
- Potential sources of methodological bias according to the Cochrane Collaboration Risk of Bias tool were evaluated in all the included studies
- Were the inclusion criteria used to select articles appropriate?
- Inclusion criteria
Including women who underwent hysterectomy regardless of abdominal, laparoscopic, or robotic-assisted surgery
Including women who received TAP block pre- or postoperation
Being an RCT
Being a comparative study between TAP block and sham or no block groups
- Exclusion criteria
Being a non-randomized study
Failing to focus on TAP block compared with sham block or no block
Being a case report, review paper, or unpublished literature
Undergoing a surgery other than hysterectomy
- Were the included studies of good quality?
- All are RCTs. Overall, the majority of trials had a low risk of bias
- Were the results similar from study to study?
- No; because of methodological heterogeneity.
- Chi square test: Assume null hypothesis that all studies are homogenous/each study is measuring an identical effect –> If p-value <0.1 –>reject null hypothesis –>significant heterogeneity
- I2 statistics: < 25% –> low heterogeneity
- Conclusion
- TAP block can provide effective analgesia for AH
- BUT the effect of TAP block in LH/RH is limited
- TAP block significantly reduced mean 24-hour morphine consumption and prolonged the time to first request for analgesic in AH only, and TAP block has limited effectiveness for participants who underwent LH or RH
- TAP block also significantly reduced the pain scores at rest and on movement postoperatively at different times in AH but not in LH or RH
- TAP block significantly reduced the rate of nausea and vomiting after the operation
- External validity: this meta-analysis had several limitations:
- High heterogeneity – factors such as different doses and types of anesthetics and different postoperative analgesic methods may impact the heterogeneity of the meta-analysis
- More RCTs with larger sample sizes in these fields are still needed to strengthen the results of meta-analysis
- Link to article
Oct 2019
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
POISE study group. Lancet 2008;371:1839-47.
- The POISE Trial is a multi-centre, blinded, randomized controlled trial of metoprolol vs placebo in patients at risk of atherosclerotic diseases undergoing noncardiac surgery.
- Intervention:
- The study drug (metoprolol vs placebo) is administered perioperatively and the effect on cardiovascular events (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal cardiac arrest)
- First dose was 100mg metoprolol given 2-4 hours before surgery; second dose was 200mg given 0-6 hours after surgery; thereafter patients were given 200mg daily for 30 days
- Study drug was given if HR >=50bpm and SBP >=100mmHg
- Outcomes
- Stroke and mortality during the 30 day post-operative period is studied.
- It was shown statistically significant that perioperative β blockers prevent non-fatal myocardial infarctions but increase the risk of non-fatal stroke and mortality
- Primary outcome: Composite of CV death, non-fatal MO and non-fatal cardiac arrest at 30 days: 5.8% (metoprolol) vs 6.9% (placebo) (p=0.0399)
- Secondary outcomes include: Death 3.1% (metoprolol) vs 2.3% (placebo) (p=0.0317) and Stroke 1.0% (metoprolol) vs 0.5% (placebo) (p=0.0053)
- Adverse events: Clinically significant hypotension 15.0% (metoprolol) vs 9.7% (placebo) (p<0.0001) and Clinically significant bradycardia 6.6% (metoprolol) vs 2.4% (placebo) (p<0.0001)
- Criticism of the trial is mainly directed at the clinically significant hypotension due to the high dose beta blocker causing more stroke in the metoprolol group
- Related guidelines include the 2014 ACC/AHA Perioperative CV evaluation and management for non-cardiac surgery
- Link to article
Aug 2019
Preoperative Hyponatremia and Perioperative Complications
Leung AA et al. JAMA 2012;172:1474-1481.
- This study investigated whether preoperative mild (130-140mmol/L) or moderate-to-severe (<130 mmol/L) hyponatremia was associated with perioperative outcomes:
- Patients – the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Participant Use Data Files-> Adults with preoperative sodium level (<135) undergoing surgery from 1/1/2005 to 31/12/2010
- Intervention - N/A
- Control – patients with preoperative normal sodium level
- Outcome (Primary) 30-day mortality; (Secondary) stroke, coronary events, pneumonia, wound infection, length of stay
- Study design:
- Observational study – Retrospective cohort study in which the study is carried out at present time and look at the past for the data
- Pros: examine multiple outcome, less costly than prospective cohort, study can be carried out in shorter time, immediate access to data
- Cons: Null hypothesis –> there is no relationship between preoperative hyponatremia with post operative mortality
- In this study 75423 patients with preoperative hyponatremia were compared with 888840 controls
- Statistical methods:
- Multivariate logistic regression: to find an equation that best predicts the probability of y variable as the function of x variable
- Non parametric quantile regression model : for studying length of stay outcome (non dichotomous data)
- Subgroup analysis to study whether baseline characteristics of the population group will affect the study result (ANA, BMI, health status , surgery type)
- Sensitivity analysis for potential selection bias – the study was repeated twice with assuming the patients who were excluded from the initial cohort because of not having preoperative sodium level with (1) normal sodium level and (2) hyponatremia.
- Missing values have undergone dummy coding
- Secondary analysis for the primary outcome according to the number of days from the preoperative sodium measurement to the time of operation
- Results:
- Primary outcome – 30day mortality: with mild hyponatremia (4.6% deaths; aOR, 1.38; 95% CI, 1.32-1.45); with moderate to severe hyponatremia (9.6% deaths; aOR, 1.72; 95% CI, 1.58-1.88) (P<0.001)
- Secondary outcomes – Coronary events, wound infection, pneumonia with aOR >1 and 95% CI not crossing 1 in preoperative hyponatremia patients. Hypo-natremia was typically associated with longer median lengths of stay by approximately 1 day for most surgical procedures during the study
- Definition of "Odds Ratio":
- Odds Ratio = Odds of exposure in cases / odds of exposure in control
- In this study, preoperative hyponatremia is associated with increased 30-day mortality even after subgroup analysis.
- Pros of the study:
- Cohort
- Large sample size
- Good subgroup analysis to study baseline characteristics of population group
- Investigate the effect of outcome with different degrees of hyponatremia (mild and moderate to severe group)
- Sensitivity analysis to minimize potential selection bias
- Secondary analysis to study the primary outcome according to the number of days from the preoperative sodium measurement to the time of OT
- Cons of the study:
- Not knowing the reason of hyponatremia
- Not mentioning any treatment given for treating hyponatremia before surgery
- Postoperative sodium level not known
- Not representing a casual relationship between sodium level and perioperative mortally/morbidity
- Individual may contribute to the study more than once
- Anesthesia mode not mentioned (GA/RA)
- External validity
- Study was performed in USA, mainly non Asian population
- However as large sample size, therefore may still be applicable to our practices
- Although this study didn’t tell whether treating hyponatremia preoperatively can improve the post-operative outcomes, preoperative sodium level may be a marker for poor prognostic outcome. There is no consensus for the preoperative sodium level, therefore anesthetists should assess the situation in a case-to-case basis, including balancing the risks and benefits of postponing the surgery for investigation and treatment of hyponatremia. But generally if elective surgery with moderate to severe hyponatremia <130 (or symptomatic hyponatremia), then should consider postponing surgery for further investigations and management
- Link to article
Aug 2019
Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood (PANDA study)
Sun LS et al. JAMA 2016;315:2312-2320.
- This trial examines whether a single anesthesia exposure in otherwise healthy young children was associated with impaired neurocognitive development and abnormal behavior in later childhood.
- Hypothesis: A single exposure to general anaesthesia in healthy children younger than 3 years was associated with, at ages 8 to 15 years, an increased risk of impaired global cognitive function (IQ) as the primary outcome and abnormal domain-specific neurocognitive functions and behaviour as secondary outcomes
- Design:
- Sibling-matched cohort design, patients from four US pediatric tertiary hospitals
- Sibling pairs within 36months in age, and between 8 to 15 years old at time of study.
- Inclusion criteria: Exposed group: had a single GA before age 3 for elective inguinal hernia OT; ASA 1 or 2; >=36 week gestation at birth VS Unexposed group: biologically related siblings (half or full) age within 3 years to exposed child; no GA before age 3; >=36 week gestation at birth
- Outcome measures
- Primary: Global cognitive function (IQ)
- Secondary: Domain specific cognitive functions and behaviour: memory, attention, motor function, language, executive function, learning, processing speed, visuospatial function, adaptive behaviour
- PANDA neuropsychological battery
- Methods: 9038 children screened ——> 105 sibling pairs with complete data and were eligible included for primary outcome analysis, and 97-105 pairs in secondary outcomes
- Results
- Mean age at testing 10.6 for exposed, 10.9 for unexposed
- Exposed received inhalational, intravenous, opioids, and adjunct caudal
- Mean duration of GA was 84min
- Mean IQ scores were NOT statistically different between the exposed and unexposed siblings, no matter the 3 age ranges of exposure (0-11months, 12-23months, 24-36 months) or duration of exposure (0-59min, 60-119min, >=120min)
- For secondary outcomes, no difference found after adjusting for sex and in same-sex sibling pairs
- Conclusions: Among healthy children with a single anesthesia exposure before age 36 months, compared with healthy siblings with no anesthesia exposure, there were no statistically significant differences in IQ scores in later childhood. Further study of repeated exposure, prolonged exposure, and vulnerable subgroups is needed.
- Limitations:
- Inguinal surgery only; single GA; Otherwise healthy, term children
- Recruitment bias - sibling cohort had higher IQs than general population
- Sex imbalance (95 males vs 10 females)
- 23 unexposed siblings had GA after 3 years old
- Link to article
Aug 2019
Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality: a Meta-Analysis
Lin MH et al. Stroke. 2019;50:1364-1371.
- New onset perioperative atrial fibrillation (AF) might be a risk factor for stroke and mortality. This meta-analysis evaluates the relationship of perioperative AF with early and late risks of mortality and stroke. In this meta-anlysis, which included 35 studies with 2458010 patients, the results showed that POAF was associated with increased risks of early stroke (odds ratio, 1.62; 95% CI, 1.47–1.80), early mortality (odds ratios, 1.44; 95% CI, 1.11–1.88), long-term stroke (HR, 1.37; 95% CI, 1.07–1.77), and long-term mortality (HR, 1.37; 95% CI, 1.27–1.49).
- Internal Validity:
- Patients – those with POAF
- Intervention / Comparison – without POAF
- Outcome (Primary) – early and late stroke risk/mortality
- Literature search: Pubmed, EMBASE, and Cochrane Library (1966 through March 2018) with no language restriction. Two investigators independently conducted the literature search. Any discrepant judgments were resolved through joint discussion. Studies found were then assessed for their quality by using the US preventive Task Force modified checklist.
- Heterogeneity: were the results similar from study to study? Look at forest plot
- Graphical display of results of meta-analysis which allow visual comparisons of all the studies included
- Individual studies are plotted as boxes with their size proportional to its weighing (sample size)
- 95% Confidence intervals were plotted with vertical reference line representing "line of no effect". P value is calculated for the strength of overall effect
- A diamond represents the 95% CI from the pooled results.
- Heterogeneity calculated using tests e.g. Chi-square test, I-square test, Tau-square test
- If the heterogeneity tests are significant (e.g. in this study, I2 >75% in early mortality, long term stroke as well as long term mortality) means that the journals included are HETEROGENOUS, which is NOT GOOD.
- External Validity - several issues to consider:
- Unknown diagnostic criteria on e.g. duration, episode, timing with reference to operation for "POAF"
- How was the AF being treated?
- Was underlying AF being picked up? (effect of pre-operative unknown chronic pAF instead of new onset perioperative AF)
- 28 out of 35 studies included were on patients with underlying cardiac pathology undergoing CABG. Applicability to other patient groups undergoing other operations? Cardiac surgery and POAF may have be more related to peri-operative cardiac tissue inflammation, etc, which could go away post-operatively. But for non-cardiac surgeries, POAF may signify a more chronic persistent poor premorbid state and hence more long term effects.
- Implications to our clinical practice:
- Any peri-operative arrhthymia is to be treated due to high benefit to risks ratio. This study, due to its heterogeneity and therefore doubtful conclusion, as well as the poor applicability to our usual patient groups, probably fails to persuade a change in our usual clinical management, which would be to treat new-onset POAF by initially trying early medical or electric conversion, and if POAF recurs or is persistent, to treat with rate control and anticoagulation. The study does however triggers thoughts on the risks and significance of peri-operative arrythmia, and suggests that even if the arrythmia goes away, maybe we should still consider consulting medical for follow up management.
- Link to article
Aug 2019
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care (TRICC Study)
Hebert PC et al. N Engl J Med 1999;340:409-417.
- This trial aimed to determine whether restrictive strategy of red cell transfusion and liberal strategy produce equivalent results in critically ill patients.
- Study design
- Equivalency trial
- 838 critically ill patients; 3 centres in Canada 1994-1997
- Randomised controlled trial to 2 groups:
- Restrictive transfusion (maintain Hb 7-9g/dL), VS
- Liberal transfusion (maintain Hb 10-12g/dL)
- Stratified according to center and APACHE II
- Patients
- Inclusion: Expected to stay in ICU for more than 24 hours; Hb < 9g/dL within 72 hours of admission to ICU and euvolemic
- 838 critically ill patients; 3 centres in Canada 1994-1997
- Exclusion: Less than 16 year old; active blood loss; chronic anaemia; brain death; imminent death; routine cardiac surgical procedure
- Outcome measures
- Primary: Death from all causes in 30 days
- Secondary: 60 day rates of death from all causes, mortality rates during the stay in ICU and hospitalisation and survival times in 30 days; organ failure
- Results
- No significant difference in 30 day mortality between restrictive vs liberal transfusion (18.7 percent vs. 23.3 percent, P= 0.11)
- Mortality rates during hospitalisation actually significantly lower in restrictive group
- Though not statistically significant, mortality rates during entire stay in ICU and 60day mortality were lower in the restrictive group
- Subgroup analysis found survival benefit with restrictive strategy esp in patients who are not as acutely ill (APACHE II score <20) and younger (<55 years old)
- No significant difference in organ dysfunction between both groups
- Significantly more pulmonary Edelman and myocardial infarction in liberal group in ICU
- Conclusions: Transfusion threshold of 7g/dL and maintain Hb 7-9 g/dL was at least as effective as and possibly superior to liberal transfusion in critically ill patient (except in active coronary ischemic syndrome)
- Link to article
May 2019
Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial
McCann ME et al. Lancet. 2019;393:664-677.
- Exposure to general anaesthetics leads to neurotoxicity in laboratory animals. However, it is controversial whether general anaesthesia in early infancy affects neurodevelopmental outcomes.
- The GAS Trial is an international randomized, controlled trial to compare the neurodevelopmental outcome at 5 years of age in patients who underwent short GA in early infancy for hernia repair VS awake-regional anaesthesia.
- The outcome studied, IQ score at 5 years, is a meaningful outcome as it has implication for long term intellectual function.
- Internal Validity:
- Patients – 722 recruited; Infants<60 weeks’ postmenstrual age; born at >26 weeks gestation, planned inguinal herniorrhaphy, without previous exposure to GA or risk factors for neurological injury.
- Intervention / Comparison – Awake regional anaesthetic vs Sevoflurance based general anaesthetic
- Outcome (Primary) – Full-scale IQ on WPPSI-III at 5 years of age
- Null hypothesis: no clinically important difference in neurodevelopmental outcome between GA and RA
- Randomization: computer based stratified+ block randomzation
- 363 awake regional; 359 GA
- Blocks of two or four in a computer-generated random-allocation sequence; allocation concealment
- stratification by site and by gestational age at birth
- The groups were similar at baseline, and the groups were treated equally aside from the allocated treatment.
- 91 families were lost to follow-up in the awake-regional anaesthesia group and 97 in the general anaesthesia group (74% follow-up). Multiple imputation under multivariate distribution to impute the missing outcome data.
- 76 protocol violations: Most violation from RA group received GA due to inadequate/failed regional block Both per-protocol and intention to treat analysis performed.
- Blinding: Partial
- Anaesthetist – aware of allocation (for sure)
- Observer (administer neurodevelopmental assessment) blinded
- Parents: informed if they asked about the group allocation (reasonable to know… What mode did the child receive), told to mask assessors about the allocation
- Results / Conclusions: Primary outcome was WPPSI-III FSIQ. Adjusted mean difference for awake-regional anaesthesia minus general anaesthesia 0·23, 95% CI –2·59 to 3·06. Intention-to-treat analysis (0·16,–2·45 to 2·78). Equivalence in WPPSI-III FSIQ at 5 years between children who received awake regional anaesthesia and GA for inguinal herniotomy (of slightly less than an hour) in infancy.
- External Validity
- Is IQ score at 5 years meaningful? It is explained in the paper that IQ at age 5-6 strongly correlated with adult IQ – implication for effect on long term intellectual function
- Is the study population similar to our patients? Male predominant study patients – explained by the higher prevalence of hernia in male. Early infancy – results cannot be translated to older children. Short operation (average OT time less than 1 hour) – cannot translate to longer operations.
- Does the result of GAS trial correlate with other trials? e.g. MASK – Also no difference between child with single exposure vs no exposure; children that had multiple anaesthetics did have an increased risk of deficits in processing speed and fine motor outcomes, and parents reported increased problems related to executive function, behaviour, and reading; however the GAS trial was not designed to address the above issue, secondary outcomes did not showed increase in other behavioural/developmental deficits. PANDA – correlate with the finding of no difference in IQ in child who received exposue to GA to their unexposed siblings.
- Implication to clinical practice: Counselling to parents: strong evidence that single episode, short duration (1 hour) GA in early infancy not having effect on child’s neurodevelopment in terms of intellectual function. Should not defer operation for the sole purpose of preventing such neurodevelopment effect – risk for delaying peration e.g. hernia complications. Still pending further research on effect on other neurocognitive domains, and the age/exposure threshold of such effect.
- Link to article
May 2019
Anesthesia awareness and the bispectral index (B-Unaware Trial)
Avidan M et al. N Engl J Med 2008;358:1097-1108.
- The B-Unaware Trial aimed to determine whether BIS-based protocol is better than end-tidal anaesthetic gas (ETAG) based protocol for decreasing anaesthesia awareness in high risk patients. All included patients were at high risk of anaesthesia awareness, as defined by at least with a major criterion or two minor criteria; the major criteria included: chronic anticonvulsants/opiates/benzodiazepines/cocaine, EF<40%, history of awareness, difficult intubation, ASA 4/5, aortic stenosis, end-stage lung disease, marginal exercise tolerance not resulting from musculoskeletal dysfunction, pulmonary hypertension, open-heart surgery, daily alcohol consumption.
- 2000 patients were randomly assigned to BIS-guided anaesthesia or ETAG-guided anaesthesia. After the operation, assessors evaluate the patients at three designated time intervals (0 to 24 hours, 24 to 72 hours, and 30 days after extubation) to determine whether the patient had awareness.
- BIS protocol would be targeting BIS range 40 to 60. ETAG group would be targeting 0.7 to 1.3MAC.
- Results: There were 967 and 974 patients from the BIS and ETAG groups. 2 cases of definite awareness in each group (absolute difference, 0%; 95% confidence interval [CI], −0.56 to 0.57%). The BIS value was greater than 60 in one case of definite anesthesia awareness, and the ETAG concentrations were less than 0.7 MAC in three cases. For all patients, the mean (±SD) time-averaged ETAG concentration was 0.81±0.25 MAC in the BIS group and 0.82±0.23 MAC in the ETAG group (P=0.10; 95% CI for the difference between the BIS and ETAG groups, −0.04 to 0.01 MAC).
- Conclusions: Based on the results from B-unaware trial, the use of BIS protocol guided anaesthesia did not lead to a lower incidence of anaesthesia awareness compared with anaesthesia protocol based on end-tidal anaesthetic concentration. But note the possible limitations as B-unaware has a quite loose definition of high risk patient based on the list of criteria, subjective assessment of true awareness - patients are repeatedly questioned by assessors which may induce false memories.
- Interpretations: In the previous B-Aware study, there was an absolute risk reduction of 0.74% in anesthesia awareness among high-risk patients to whom anesthesia was administered according to a BIS-guided protocol, as compared with conventional care. Conversely, in the B-Unaware Trial, the authors did not reproduce the results of previous studies that reported a lower incidence of anesthesia awareness with BIS monitoring, and the use of the BIS was not associated with reduced administration of volatile anesthetic gases. Anesthesia awareness occurred even when BIS values and ETAG concentrations were within the target ranges. Such findings do not support routine BIS monitoring as part of standard practice.
- Link to article
Mar 2019
Ketamine as a Rapid Sequence Induction Agent in the Trauma Population: A Systematic Review
Baekgaard et al. Anesthesia & Analgesia. 2019;128:504-510.
- Systematic review: A review in which evidence on a topic or research question has been systematically identified, appraised and summarised according to pre-determined criteria. A systematic review may incorporate meta-analysis, but don’t have to.
- Meta-analysis: A statistical technique which combines the results of several studies into a single estimate, giving more weight to larger studies. Forest plots are commonly used to represent the meta-analysis of results
- This systematic review addressed the following:
- Population – Adult trauma patients intubated in pre-hospital setting or in AED within 1h of arrival
- Intervention – use of either ketamine
- Comparison – vs any other induction agent
- Outcome – Primary (30-day mortality) and Secondary (in-hospital mortality, info on blood transfusion, hospital stay length)
- There was a comprehensive literature search. Major bibliographic databases were searched (Cochrane, EMBASE, Pubmed), with no language restrictions. Search was done by 2 authors and interrater reliability was checked with Cohen kappa statistics.
- Selection criteria were appropriate. However, the number of studies included was limited - 3 cohorts and 1 RCT. The RCT in 2009 has low risk of bias; the Vietnam war cohort from 1976 has serious risk of bias; the other 2 cohorts have moderate risks of bias. Cochrane tool for assessing risk of bias was used for RCT's and Newcastle-Ottawa Scale for risk of bias was used for non-randomized trials. Because of methodological heterogeneity in terms of risk of bias in the studies it was not found meaningful to perform a meta-analysis on the studies.
- Conclusion: Existing evidence cannot exclude benefit or harm of ketamine compared to other drugs. Larger RCTs are warranted to establish more solid evidence.
- In terms of external validity, we thought that maybe the outcomes investigated in this study are not as interesting to anaesthetists (we may be more interested in intubation success/attempts/difficulties/desaturation episodes), but the outcomes in this study are admittedly more “significant” in terms of patient outcomes. Also, perhaps ketamine is not as widely utilised in AED/out of hospital setting and hence the question asked was not addressed in most literature.
- Link to article
Mar 2019
Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial
Myles PS et al. Lancet 2004;363:1757-63.
- A prospective, randomised, double-blind trial to assess whether BIS monitoring decrease incidence of awareness during relaxant GA in routine surgical patient at high risk of awareness.
- Adult patients at high risk of awareness were recruited, including
- Caesarean section, high-risk cardiac surgery (eg, ejection fraction <30%, cardiac index <2.1 L/min per m2, severe aortic stenosis, pulmonary hypertension, or undergoing off-pump coronary artery bypass graft surgery), acute trauma with hypovolaemia, rigid bronchoscopy, significant impairment of cardiovascular status and expected intraoperative hypotension requiring treatment, severe end-stage lung disease, past history of awareness, anticipated difficult intubation where an awake intubation technique was not planned, known or suspected heavy alcohol intake, chronic benzodiazepine or opioid use, current protease inhibitor therapy
- Patients were randomised assigned to receive BIS guided anaesthesia or routine care group. BIS level was kept between 40-60 from the start of laryngoscopy to time of wound closure.
- Primary outcome was the incidence of confirmed awareness. Three structured interview was arranged 2-6hr after surgery, 24-36 hrs after surgery and 30 days postoperatively. All potential awareness cases were assessed by an independent endpoint adjudication committee.
- Secondary outcomes were potential awareness, recovery times, hypnotic drug administration, incidence of marked hypotension, anxiety and depression, patient’s satisfaction, major complication and 30 days mortality.
- Findings
- Of 2463 eligible and consenting patients, 1225 were assigned to the BIS group and 1238 to the routine care group. There were two reports of awareness in the BIS-guided group and 11 reports in the routine care group (p=0.022). BIS-guided anaesthesia reduced the risk of awareness by 82% (95% CI 17–98%).
- BIS monitoring had little effect on the time needed to recover from GA. No significant difference in death or post op complication.
- Interpretation
- BIS-guided anaesthesia reduces the risk of awareness in at-risk adult surgical patients undergoing relaxant general anaesthesia. With a cost of routine BIS monitoring at US$16 per use in Australia and a number needed to treat of 138, the cost of preventing one case of awareness in high-risk patients is about $2200.
- Link to article
Feb 2019
Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study
Wijeysundera et al. Lancet 2018;391:2631-40.
- A multicentre, international prospective cohort study to compare preoperative subjective assessment with alternative markers of fitness, including Duke Activity Status Index (DASI) questionnaire, for predicting death or complications after major elective non-cardiac surgery.
- The study concluded that subjectively assessed functional capacity should not be used for preoperative risk evaluation. Subjective assessment had 19.2% sensitivity and 94.7% specificity for identifying inability to attain 4METS during cardiopulmonary exercise testing. Only DASI scores were associated with predicting the primary outcome. Hence, the authors also concluded that clinicians could use a measure such as DASI for more accurate cardiac risk assessment.
- Advantages of cohort study: finding the risk factors; temporal relationship between risk factors & outcomes; sometimes RCT is not ethical to perform; able to study rare exposure; able to measure multiple outcomes
- Disadvantages of cohort study: need large sample size; need long follow-up duration; not good for disease with long latency; potential lost to FU; high study cost; susceptible to selection bias
- Link to Duke Activity Status Index questionnaire: Here
- Link to tool for critical appraisal of cohort studies: Here
- Link to article
Feb 2019
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
WOMAN Trial Collaborators Lancet 2017;389:2105-16.
- The WOMAN Trial was designed to evaluate the effects of tranexamic acid in postpartum haemorrhage.
- Women over the age of 16 were recruited if they had post-partum haemorrhage, defined as blood loss of 500ml after vaginal delivery or 1000ml after caesarean delivery or any blood loss sufficient to cause haemodynamic compromise. 20060 patients were randomised to receive 1g tranexamic acid over 10 minutes or placebo. A second dose was given if bleeding continued after 30 minutes or stopped and restarted within 24 hours.
- The primary outcome was a composite of death from all causes or hysterectomy within 42 days of randomisation.
- The main findings for those given tranexamic acid were:
- Reduced death due to bleeding, RR 0.81
- RR 0.69 when given within 3 hours of delivery
- No reduction when given more than 3 hours after delivery
- Did not reduce hysterectomy or all-cause mortality
- Did not increase the risk of thromboembolic events
- Link to article
Jan 2019
Effect of cricoid pressure compared with a sham procedure in the rapid sequence induction of anesthesia (The IRIS Randomized Clinical Trial)
Birenbaum et al. JAMA Surgery 2019;154(1):9–17.
- In this large non-inferiority RCT comparing cricoid vs sham procedure on the rate of pulmonary aspiration, the study investigators failed to demonstrate the non-inferiority of the sham procedure in preventing pulmonary aspiration.
- Non-inferiority trial design, particularly its applications and statistical background including the slightly unusual null/alternative hypotheses were discussed.
- Factors affecting sample size calculation: effect size, alpha (predefined significance level), beta (lower beta error means higher power), variance, test sensitivity and design, as well as non-statistical factors. The actual pulmonary aspiration rate from the study data was lower than that predicted by the investigators, so the sample size was inadequate.
- Intention-to-treat ITT vs Per-protocol PP analysis: ITT is usually the preferred less biased analytical approach for superiority trials. (i.e. analyse all randomized patients regardless of whether they received the assigned intervention or not). However for non-inferiority trials, ITT which includes dropouts etc. tends to bias the results towards equivalence. A PP analysis which analyses patients who had no major protocol violations is more likely to identify any true treatment differences, although there could be bias in either direction. Therefore, it is recommended for non-inferiority trials to perform both analyses and draw conclusion if both produce the same results.
- For the external validity, it is reasonable to conclude that cricoid pressure is still a safe option for patients with aspiration risk, since from the secondary outcomes the median intubation time for the cricoid group was only longer by 4s and rates of difficult intubation or impossible intubation were not different between groups.
- Link to article
Jan 2019
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
The Magpie Trial Collaborative Group. Lancet 2002;359(9321):1877–1890.
- The Magpie (MAGnesium sulphate for Prevention of Eclampsia) Trial was a large multi-centre international trial designed to evaluate the effects of magnesium sulphate on women and their babies.
- Patients were recruited if they had pre-eclampsia and there was uncertainty about whether to use magnesium sulphate. They were randomized to receive either magnesium sulphate or placebo. It was double-blinded and just over 10000 women were recruited.Primary outcomes were eclampsia and, for women randomized before delivery, death of the baby before discharge from hospital. Secondary outcomes were measures of serious maternal morbidity (respiratory depression, respiratory arrest, pneumonia, cardiac arrest, coagulopathy, renal failure, liver failure, pulmonary oedema, and cerebral haemorrhage), toxicity and other side effects of magnesium sulphate.
- The main findings for those allocated magnesium sulphate were:
- Significantly fewer eclamptic convulsions (Relative risk = 0.58, NNT= 93)
- NNT = 63 for women with severe pre-eclampsia
- Maternal mortality was lower
- A reduction in the risk of placental abruption was observed
- No clear differences between the groups in any measures of maternal morbidity
- Link to article
Dec 2018
Intravenous infusion of lidocaine significantly reduces propofol dose for colonoscopy: a randomised placebo-controlled study
Forster C et al. British Journal of Anaesthesia 2018 Nov 1;121(5):1059-64.
- In terms of internal validity, Student’s T-test may not be appropriate to analyse the primary outcome data as the population may not be normally distributed
- Significant reduction of propofol dose in the study may not translate to meaningful clinical outcome; the more meaningful question may be the hemodynamic or respiratory effects of decreasing the consumption of propofol
- Link to article
Dec 2018
Restrictive versus liberal fluid therapy for major abdominal surgery
Myles PS et al. New England Journal of Medicine 2018 May 10.
- A landmark study comparing restrictive vs liberal therapy for major abdominal surgery in at-risk patient groups
- Randomisation – highlighted the differences between simple randomisation, block randomisation and stratified randomisation
- Blinding was not possible in this study
- There is inadequate explanation from the authors about maintaining haemodynamic targets within the usual practical/ethical standards, for example, in the restrictive group the investigators restricted fluid regardless of the hemodynamic or other clinical parameters such as oliguria — and treated with pressors instead. It may seem to deviate from our normal practice
- Link to article